Manufacturing roundup: Finnish pharma Orion investing $30M+ to boost production; Biosyngen opens new Singapore facility

The Finnish pharmaceutical company Orion is planning to invest around €30 million ($32.7 million) to boost its production capacity. According to a release, this investment will focus on increasing the production of inhalers at its […]

No Picture

STAT+: Pharmalittle: Drug-wholesaler owner indicted for alleged role in diverting HIV medicines; Catalent linked to Regeneron drug rejection

Top of the morning to you. A delicious cool breeze and shiny sun are hovering over the Pharmalot campus, where birds are singing, mascots are barking, and another cup of stimulation is brewing (our choice […]